Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Academic Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Decision analysis"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Cost Effectiveness of Denosuma...
Similar by person
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Decision analysis
Annual reports
1
Cardiovascular disease
1
Cholesterol lowering
1
Constipation
1
Cost-effectiveness
1
Cost-effectiveness analysis
1
GRI
1
Irritable bowel syndrome
1
JSE
1
King III
1
Kosten-Wirksamkeits-Analyse
1
Linaclotide
1
Markov model
1
ROE
1
Secondary prevention
1
Statin therapy
1
Theorie
1
Theory
1
corporate governance
1
environmental sustainability
1
more ...
less ...
Online availability
All
Undetermined
1
Type of publication
All
Article
1
Language
All
Undetermined
1
Author
All
Carmena, Rafael
1
Chu, Paula
1
Drummond, Michael
1
Graff, Jennifer
1
Greten, Heiner
1
Pandya, Ankur
1
Shepherd, James
1
Taylor, Douglas
1
Thompson, David
1
Weinstein, Milton
1
Wenger, Nanette
1
more ...
less ...
Published in...
All
The European Journal of Health Economics
1
Source
All
RePEc
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study
Taylor, Douglas
;
Pandya, Ankur
;
Thompson, David
;
Chu, Paula
- In:
The European Journal of Health Economics
10
(
2009
)
3
,
pp. 255-265
Persistent link: https://www.econbiz.de/10005004366
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
